干细胞研究：克隆、治疗与科学欺诈。

Stem cell research: cloning, therapy and scientific fraud.

作者信息

Rusnak A J, Chudley A E

机构信息

Program in Genetics and Metabolism, Children's Hospital, and Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

Clin Genet. 2006 Oct;70(4):302-5. doi: 10.1111/j.1399-0004.2006.00678.x.

DOI:10.1111/j.1399-0004.2006.00678.x

PMID:16965321

Abstract

Stem cell research has generated intense excitement, awareness, and debate. Events in the 2005-2006 saw the rise and fall of a South Korean scientist who had claimed to be the first to clone a human embryonic stem cell line. From celebration of the potential use of stem cells in the treatment of human disease to disciplinary action taken against the disgraced scientists, the drama has unfolded throughout the world media. Prompted by an image of therapeutic cloning presented on a South Korean stamp, a brief review of stem cell research and the events of the Woo-suk Hwang scandal are discussed.

摘要

干细胞研究引发了强烈的兴奋、关注和争论。在2005年至2006年期间，一位韩国科学家经历了从声名鹊起到身败名裂的过程，他曾宣称自己是首个克隆出人类胚胎干细胞系的人。从对干细胞在治疗人类疾病方面潜在用途的颂扬，到对这位身败名裂科学家的纪律处分，这一戏剧性事件在全球媒体上不断上演。受一枚韩国邮票上所展示的治疗性克隆图像的启发，本文对干细胞研究以及黄禹锡丑闻事件进行简要回顾。